banner
LightNews
charlotteh560.bsky.social
Charlotte Harrison
@charlotteh560.bsky.social
24 followers 41 following 3 posts
Freelance science writer and editor
Posts Media Videos Starter Packs
charlotteh560.bsky.social
Charlotte Harrison @charlotteh560.bsky.social · 14d
Researchers are increasingly using organ chips and organoids alongside or instead of animals to model drug safety, biological mechanisms and rare diseases. My latest for Lab Animal @natureportfolio.nature.com rdcu.be/eH7Pj
With insight from @nc3rs.bsky.social @emulatebio.bsky.social and others
New approach methodologies gain momentum, providing human-relevant alternatives to animal models
Lab Animal - Researchers are increasingly using organ-on-chips and organoids alongside or instead of animals to model drug safety, biological mechanisms and rare diseases.
rdcu.be
1
charlotteh560.bsky.social
Charlotte Harrison @charlotteh560.bsky.social · Aug 6
Can amylin-based drugs upstage GLP-1 agonists? They could avoid muscle loss and gastrointestinal side effects of current obesity therapies. My latest for @natbiotech.nature.com rdcu.be/ezwbM
Can amylin-based drugs upstage GLP-1 agonists?
Nature Biotechnology - Analogs of the pancreatic peptide hormone amylin are making strides in obesity as developers zoom in on oral drugs that can emulate or even improve on injectable GLP-1...
rdcu.be
3 8
Reposted by Charlotte Harrison
natbiotech.nature.com
Nature Biotechnology @natbiotech.nature.com · May 19
Biopharma dives into tumor-seeking radioactive drugs www.nature.com/articles/s41...
Biopharma dives into tumor-seeking radioactive drugs - Nature Biotechnology
Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy cancerous cells with minimum dama...
www.nature.com
2 4
charlotteh560.bsky.social
Charlotte Harrison @charlotteh560.bsky.social · Feb 18
Hello Bluesky! Let’s try a first post…here’s my latest story for @naturebiotech.bsky.social on @vertexpharma.bsky.social non-opioid pain killer and next-gen NaV1.8 inhibitors in the pipeline rdcu.be/ealj0
Vertex’s opioid-free drug for acute pain wins FDA approval
Nature Biotechnology - Society, patients and clinicians welcome a much-needed non-opioid pain medication. Vertex’s first-in-class analgesic Journavx could soon be followed by a new generation...
rdcu.be
4 3